Gastric cancer (GC) ranks fifth in cancer incidence and fourth in cancer-related mortality worldwide. Reactive oxygen species (ROS) are highly oxidative oxygen-derived products that have crucial roles in cell signaling regulation and maintaining internal balance. ROS are closely associated with the occurrence, development, and treatment of GC. This review summarizes recent findings on the sources of ROS and the bidirectional regulatory effects on GC and discusses various treatment modalities for GC that are related to ROS induction. In addition, the regulation of ROS by natural small molecule compounds with the highest potential for development and applications in anti-GC research is summarized. The aim of the review is to accelerate the clinical application of modulating ROS levels as a therapeutic strategy for GC.
机构:
Univ Rennes 2, Ecole Normale Super Rennes, Lab Movement Sport & Hlth Sci, Bruz, FranceUniv Rennes 2, Ecole Normale Super Rennes, Lab Movement Sport & Hlth Sci, Bruz, France
机构:The Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology,Division of Pulmonary and Critical Care Medicine, Department of Medicine, The Feinberg School of Medicine
Lucas B Sullivan
Navdeep S Chandel
论文数: 0引用数: 0
h-index: 0
机构:The Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology,Division of Pulmonary and Critical Care Medicine, Department of Medicine, The Feinberg School of Medicine